15 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27003516	78	Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold.	The University of Kansas
26086931	38	Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators.	Shandong University
25901531	211	Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.	Sloan-Kettering Institute For Cancer Research
25027801	8	Development of radamide analogs as Grp94 inhibitors.	The University of Kansas
24673104	185	Identification of novel HSP90a/ß isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington's disease.	Vertex Pharmaceuticals
24332488	11	Correlation between chemotype-dependent binding conformations of HSP90a/ß and isoform selectivity-Implications for the structure-based design of HSP90a/ß selective inhibitors for treating neurodegenerative diseases.	Vertex Pharmaceuticals
22938030	22	EC144 is a potent inhibitor of the heat shock protein 90.	Biogen Idec
20055425	29	Heat shock protein 90: inhibitors in clinical trials.	Biogen Idec
31839539	60	Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1.	Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)
31663736	15	Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions.	China Pharmaceutical University
30351001	16	Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis.	China Pharmaceutical University